← Back
$AVIR All transactions

Atea Pharmaceuticals, Inc.

A

$ Value

$0

Shares

108,000

Price

$0

Filed

Feb 3

Insider

Name

Foster Wayne

Title

EVP, Chief Accounting Officer

CIK

0001709769

Roles

Officer

Transaction Details

Transaction Date

2026-01-31

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

108,000

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. | The original grant of 100,000 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026. | Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026. | The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2026 such that the option is fully vested on January 31, 2030.

Filing Info

Accession No.

0001193125-26-036261

Form Type

4

Issuer CIK

0001593899

Foster Wayne's History

Date Ticker Type Value
2026-01-31 AVIR M
2026-01-31 AVIR F $51K
2026-01-31 AVIR M $0
2026-01-31 AVIR M $0
2026-01-31 AVIR A $0

Other Insiders at AVIR (90d)

Insider Bought Sold Last
Sommadossi Jean-Pierre
President, CEO, and Chairman
2026-02-03
Corcoran Andrea
See Remarks
2026-01-31
Foster Wayne
EVP, Chief Accounting Officer
2026-01-31
Horga Maria Arantxa
Chief Medical Officer
2026-01-31
Vavricka John
Chief Commercial Officer
2026-01-31
Hammond Janet MJ
Chief Development Officer
2026-01-31